Niamh Coleman

9PUBLICATIONS
68CO-AUTHORS
Predictive and prognostic markersMolecular targetsSolid tumoursGene and molecular therapyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 01, 2026
Tumor-Agnostic Therapies: Translating Scientific Breakthroughs Into Global Implementation.

|Jan 20, 2026
Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2.

Niamh Coleman, Zihan Wei, A John Iafrate

|Jan 08, 2026
From Biology to Bedside: Challenges and Strategies in Developing Combination Cancer Therapies in Early-Phase Trials.

Niamh Coleman, R Donald Harvey, David S Hong

|May 20, 2024
Challenges and opportunities in the immunotherapy era: balancing expectations with hope in small-cell lung cancer.

Raza Khan, Niamh Coleman

|Dec 21, 2023
Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.

Vivek Subbiah, Niamh Coleman, Sarina A Piha-Paul

|Jan 05, 2023
HRAS Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma.

Niamh Coleman, Kathrina L Marcelo, Julia F Hopkins

Pageof 2

Frequent Collaborators

5 joint publications

David S Hong

2 joint publications

Xiuning Le

2 joint publications

Lingzhi Hong

2 joint publications

Vivek Subbiah